The 33-year-old woman said: "I know this disease can take people quickly. I am so grateful for every day he is here." ...
PRESS RELEASE AB SCIENCE REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026 AND KEY EVENTS OF THE PERIODChange in AB Science's ...
Biotechs developing therapeutics to treat rare diseases include two that received FDA approvals this year for drugs to treat ...
A new review charts how stem cell-derived human microglia, brain organoids and chimeric mice are overcoming the genetic and ...
Former NASCAR driver Darrell Waltrip recently announced a diagnosis of frontotemporal dementia (FTD). Waltrip, a 3-time ...
Anthropic recently disclosed five cases in which users hid their countries while asking Claude for help enhancing pathogens ...
High-density brain recordings in awake surgical patients reveal that imagined speech shares a supramodal planning network ...
Researchers developed a nanopore sequencing pipeline that may improve genetic diagnosis of repeat expansion disorders, ...
On October 5, 2026, Shionogi & Co., Ltd. entered into an agreement to acquire all shares of IntraBio Inc., a US biopharmaceutical company specializing in the rare neurological disease field, for 2 ...
On October 5, 2026, Shionogi & Co., Ltd. announced that it would acquire the US-based rare disease drug company IntraBio for ...
Welltica+ on MSN
Researchers explain the first signs of the muscle disease ALS
This video delves into the subtle, early physical changes that could signal the onset of ALS (amyotrophic lateral sclerosis).
One of the most anticipated innovations is the development of the inmate skills IT platform, a digital ecosystem entirely covered by funds for 4.94 million euros, which will allow tracking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results